Novel transcript, antisense to NFATC1

Novel transcript, antisense to NFATC1 (ENSG00000275186) is an annotated long non-coding RNA (lncRNA) gene located antisense to the NFATC1 (Nuclear Factor of Activated T-Cells 1) locus[5]. As a lncRNA, it does not encode a protein and is instead part of the growing class of natural antisense transcripts (NATs) that are transcribed from the opposite DNA strand relative to a protein-coding gene—in this case, NFATC1. Antisense lncRNAs have been broadly implicated in the regulation of gene expression through mechanisms including modulation of chromatin structure, transcriptional interference, and effects on RNA stability or processing[4][6][2][10]. However, there is currently no evidence that this particular transcript, ENSG00000275186, functions as a therapeutic target or that it directly interacts with drugs or is associated with a disease phenotype. No well-established aliases or abbreviations are reported for this transcript[5]. Its main functions, as inferred from the overall knowledge of antisense lncRNAs, may relate to the fine-tuning or repression/activation of the sense (NFATC1) transcript, possibly via epigenetic or post-transcriptional mechanisms[4][6][2][10]. ENSEMBL and GeneCards classify it strictly as a non-coding RNA associated with the lncRNA class[5]. Key points: - This transcript is a long non-coding RNA and is not a protein, receptor, enzyme, or other classical drug target. - There is no evidence it is itself a disease driver, drug target, or clinical biomarker. - It is best described as "Novel transcript, antisense to NFATC1". - No interacting drugs, mechanisms of action, or safety concerns are currently associated with this molecule. - Main biological role: potential regulation of NFATC1 expression, as inferred from broader studies of antisense transcription[2][4][6][10][5].